← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Teriflunomid currently has availability issues reported in 4 European registers: Austria, Germany, Italy, Sweden.
Shortage ATC L04AK02 · also listed as: TERIFLUNOMID · TERIFLUNOMIDE · data refreshed 8 September 2026
As of 8 September 2026, 4 of the 9 tracked registers list current availability issues for Teriflunomid, covering 8 affected product presentations. The longest-running open report was filed in Austria on 2025-01-31 and has now been open for about 20 months. Where agencies state a cause, unexpectedly high demand lead with 3 of the 6 stated-cause reports, followed by manufacturing problems with 2. The furthest expected-resolution date currently on file is 2026-11-16; the earliest is 2026-10-30. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Austria reported first (2025-01-31), with Germany following roughly 17 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Teriflunomid is coded L04AK02 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Limited availability Terebyo 14 mg - Filmtabletten | 2025-01-31 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Teriflunomid PUREN 14 mg Filmtabletten | 2026-06-15 | 2026-10-30 | Probleme in der Herstellung Alternatives: Teriflunomid PUREN 14 mg Filmtabletten - Einreichungsnummer: 7011033 | register ↗ |
| 🇮🇹 Italy | Shortage TEREBYO + 4 more productsTERIFLUNOMIDE ABDI TERIFLUNOMIDE ACCORD TERIFLUNOMIDE DR. REDDY'S TERIFLUNOMIDE VIATRIS PHARMA | 2025-06-16 | 2026-11-16 | Elevata richiesta Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
| 🇸🇪 Sweden | Shortage Teriflunomide Vivanta 14 mg Filmdragerad tablett | 2026-01-12 | 2026-08-03 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Teriflunomid in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | TERIFLUNOMIDE ABDI | Shortage | 2026-10-12 | 2026-11-16 | Motivi commerciali |
| 🇮🇹 IT | TERIFLUNOMIDE ACCORD | Shortage | 2026-08-29 | — | Elevata richiesta |
| 🇮🇹 IT | TERIFLUNOMIDE VIATRIS PHARMA | Shortage | 2026-07-23 | — | Problemi produttivi |
| 🇩🇪 DE | Teriflunomid PUREN 14 mg Filmtabletten | Shortage | 2026-06-15 | 2026-10-30 | Probleme in der Herstellung |
| 🇮🇹 IT | TEREBYO | Shortage | 2026-05-31 | — | Elevata richiesta |
| 🇸🇪 SE | Teriflunomide Vivanta 14 mg Filmdragerad tablett | Shortage | 2026-01-12 | 2026-08-03 | |
| 🇮🇹 IT | TERIFLUNOMIDE DR. REDDY'S | Shortage | 2025-06-16 | — | Elevata richiesta: forniture discontinue |
| 🇦🇹 AT | Terebyo 14 mg - Filmtabletten | Limited availability | 2025-01-31 | — |
Yes. As of 8 September 2026, availability issues are reported in: Austria, Germany, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-30 to 2026-11-16. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
7 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Teriflunomid: BASG (Austria), BfArM (Germany), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Teriflunomid — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/teriflunomid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Teriflunomid availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/teriflunomid/">Teriflunomid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>